CEO and Fund Manager, Renaissance Venture Capital Fund
Nobel Laureate, Professor of Biology, Caltech
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Co-Founder and CEO, DNAnexus
The Washington Biotechnology & Biomedical Association is organizing an event February 24 on how scientists can make the career transition from academia to industry. Mike Gallatin of Calistoga Pharmaceuticals, Jonathan Drachman of Seattle Genetics, and Kenneth Ferguson of Imvaxyn will speak on a panel moderated by Ulrich Mueller of the Fred Hutchinson Cancer Research Center. For more information, click here.